(427 days)
No
The description focuses on standard hematology analysis techniques (impedance, photometry) and basic data storage/connectivity features. There is no mention of AI, ML, or advanced data processing beyond standard analysis and storage.
No.
The device is an in-vitro diagnostic hematology analyzer that quantifies blood parameters, not a device that directly treats or alleviates a disease.
Yes
The "Intended Use / Indications for Use" states that the device is "designed for in-vitro-diagnostic use in clinical laboratories" and "is indicated for use to identify patients with hematologic parameters within and outside of established reference ranges," which are functions of a diagnostic device.
No
The device description clearly outlines hardware components such as a bench top analyzer, cap piercing function, impedance and photometric methods, LCD display, keypad, USB ports, and optional built-in printer. While it has software, it is an integral part of a physical device.
Yes, the provided text explicitly states that the Diatron Abacus 3CP System is an IVD (In Vitro Diagnostic).
The "Intended Use / Indications for Use" section clearly states: "The Diatron Abacus 3CP System is a quantitative multi-parameter automated hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories..."
N/A
Intended Use / Indications for Use
The Diatron Abacus 3CP System is a quantitative multi-parameter automated hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories for enumeration of the following parameters: WBC, LYM%, LYM#, MID%, MID#, GRA%, GRA#, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV in K3EDTA anti coagulated venous whole blood samples. The Diatron Abacus 3CP is indicated for use to identify patients with hematologic parameters within and outside of established reference ranges.
Product codes
GKZ
Device Description
The 'Abacus 3CP' is a fully automated, bench top hematology cell counter with a cap piercing function. It uses the impedance-method for counting cells passing through a small aperture, and measures the hemoglobin content of red blood cells using a photometric method. The analyzer features a color graphical LCD display module and a foil keypad of 29 keys including 6 software buttons, 6 function keys and a START button. The instrument allows printing reports to an external printer (USB port), or can have an optional built-in printer module. Its internal memory is capable of storing 1000 records with full histograms, and individual patient data. The QC measurements are stored in a separate database. The software operating the instrument can be updated by using a USB flash memory device. The instrument can be connected to a host computer for uploading records in its memory through a USB SLAVE port (USB B) or serial link (RS232). Archiving records to an USB flash memory device is also possible.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
in clinical laboratories
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
All required software and system verification and validation procedures have been executed and analyzed per FDA recommended standards and the Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells. All risk and hazard analysis have been performed and documented per ISO 14971 guidelines. All performance and accuracy data and data analysis in this submission support and substantiate equivalence to the selected predicate device (Abbott CELL-DYN® 1800 (K030513)).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 864.5220 Automated differential cell counter.
(a)
Identification. An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.(b)
Classification. Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”
0
2 2012 AUG
510(k) Summary
| 510(k) Summary | |
|---|---|
| Submitter: | Diatron US Inc. |
| 14026 W. 107th Street | |
| Lenexa, Kansas 66215-2005 | |
| Contact | |
| Person: | Michael Switzer, Director, Quality Assurance |
| P: 954-790-9550 | |
| F: 954-827-2644 | |
| E: mike.switzer@diatron.com | |
| Date | |
| Prepared: | April 27, 2012 |
| Trade Name: | Abacus 3CP, Automated Hematology Analyzer |
| Classification: | Class II |
| Automated Differential Cell Counter | |
| 21 CFR §864.5220 | |
| Product | |
| Code: | GKZ |
| Predicate | |
| Device(s): | The subject device is equivalent to the following device: |
| Abbott CELL-DYN® 1800 (K030513) | |
| Device | |
| Description: | The 'Abacus 3CP' is a fully automated, bench top hematology cell counter with a cap |
| piercing function. It uses the impedance-method for counting cells passing through a | |
| small aperture, and measures the hemoglobin content of red blood cells using a | |
| photometric method. The analyzer features a color graphical LCD display module and | |
| a foil keypad of 29 keys including 6 software buttons, 6 function keys and a START | |
| button. The instrument allows printing reports to an external printer (USB port), or can | |
| have an optional built-in printer module. Its internal memory is capable of storing 1000 | |
| records with full histograms, and individual patient data. The QC measurements are | |
| stored in a separate database. The software operating the instrument can be updated | |
| by using a USB flash memory device. The instrument can be connected to a host | |
| computer for uploading records in its memory through a USB SLAVE port (USB B) or | |
| serial link (RS232). Archiving records to an USB flash memory device is also possible. | |
| Indications for | |
| Use: | The Diatron Abacus 3CP System is a quantitative multi-parameter automated |
| hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories for | |
| enumeration of the following parameters: WBC, LYM%, LYM#, MID%, MID#, GRA%, | |
| GRA#, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV in K3EDTA anti- | |
| coagulated venous whole blood samples. The Diatron Abacus 3CP is indicated for use | |
| to identify patients with hematologic parameters within and outside of established | |
| reference ranges. | |
| Functional | |
| and Safety | |
| Testing: | To verify that device design met it's functional and performance requirements, a |
| representative sample of the device underwent software and system verification and | |
| validation testing, in accordance with Class II Special Controls Guidance Document: | |
| Premarket Notifications for Automated Differential Cell Counters for Immature or | |
| Abnormal Blood cells. A risk and hazard analysis was performed per ISO 14971. |
1
1
| Substantial | Similarities | |||
|---|---|---|---|---|
| Equivalence: | Item | Diatron Abacus 3CP | Abbott CELL-DYN 1800 | |
| Indication for Use | The Diatron Abacus 3CP System is a | |||
| quantitative multi-parameter automated | ||||
| hematology analyzer designed for in-vitro- | ||||
| diagnostic use in clinical laboratories for | ||||
| enumeration of the following parameters: | ||||
| WBC, LYM%, LYM#, MID%, MID#, | ||||
| GRA%, GRA#, RBC, HGB, HCT, MCV, | ||||
| MCH, MCHC, RDW, PLT, MPV in | ||||
| K3EDTA anti-coagulated venous whole | ||||
| blood samples. The Diatron Abacus 3CP | ||||
| is indicated for use to identify patients with | ||||
| hematologic parameters within and | ||||
| outside of established reference ranges. | The CELL-DYN 1800 System is an | |||
| automated, multiparameter | ||||
| hematology analyzer designed to | ||||
| report sixteen parameters relating | ||||
| to the cells of EDTA-anticoagulated | ||||
| blood. | ||||
| Number of | ||||
| Parameters | 16 | Same | ||
| Methodology | WBC = Impedance | |||
| LYM = Calculated | ||||
| LYM% = Derived | ||||
| MID = Calculated | ||||
| MID% = Derived | ||||
| GRA = Calculated | ||||
| GRA% = Derived | ||||
| RBC = Impedance | ||||
| HGB = Photometric | ||||
| HCT = Calculated | ||||
| MCV = Derived | ||||
| MCH = Calculated | ||||
| MCHC = Calculated | ||||
| RDW = Derived | ||||
| PLT = Impedance | ||||
| MPV = Derived | Same | |||
| Sample Type | K3 EDTA anticoagulated venous whole | |||
| blood | Same | |||
| Sample Container | Open and Closed | Same | ||
| Sampling System | Manual | Same | ||
| Samples per hour | 60 | Same | ||
| Aperture Diameter | WBC 100 µm; RBC/PLT 80 µm | Same | ||
| Differences | ||||
| Item | ||||
| Sample Volume | Diatron Abacus 3CP | |||
| Open Vial Mode – 100 µL | ||||
| Closed Vial Mode – 100 µL | Abbott CELL-DYN 1800 | |||
| Open Vial Mode – 30 µL | ||||
| Closed Vial Mode - 450 µL | ||||
| Performance: | All required software and system verification and validation procedures have been executed | |||
| and analyzed per FDA recommended standards and the Class II Special Controls | ||||
| Guidance Document: Premarket Notifications for Automated Differential Cell Counters for | ||||
| Immature or Abnormal Blood Cells. All risk and hazard analysis have been performed and | ||||
| documented per ISO 14971 guidelines. All performance and accuracy data and data | ||||
| analysis in this submission support and substantiate equivalence to the selected predicate | ||||
| device (Abbott CELL-DYN® 1800 (K030513)). | ||||
| Conclusion: | Diatron considers the Abacus 3CP to be equivalent to the predicate device listed | |||
| above. This conclusion is based upon the devices' similarities in principles of | ||||
| operation, technology, and indications for use. | ||||
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States of America. The seal features the department's name arranged in a circular pattern around the edge. In the center is a stylized emblem that resembles a bird or abstract human figures, symbolizing health and human services.
10903 New Hampshire Avenue Silver Spring, MD 20993
AUG 0 2 2012
Diatron US Inc. c/o Mr. Michael Switzer Director, Quality Assurance 14026 W. 107th Street Lenexa. KS 66215-2005
Re: K111534
Trade/Device Name: Abacus 3CP Regulation Number: 21 CFR § 864.5220 Regulation Name: Automated differential cell counter Regulatory Class: Class II Product Code: GKZ Dated: July 30, 2012 Received: July 31, 2012
Dear Mr. Switzer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
3
Page 2 - Mr. Michael Switzer
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Riena Philip
Maria M. Chan, Ph.D.
Director Division of Immunology and Hematology Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
Indications for Use Form
510(k) Number (if known): K111534
Device Name: Abacus 3 CP
Indications for Use:
The Diatron Abacus 3CP System is a quantitative multi-parameter automated hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories for enumeration of the following parameters: WBC, LYM%, LYM#, MID%, MID#, GRA%, GRA#, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV in KgEDTA anticoagulated venous whole blood samples. The Diatron Abacus 3CP is indicated for use to identify patients with hematologic parameters within and outside of established reference ranges.
Prescription Use X AND/OR (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurregce of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Division Sign off
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K111534